Company intelligence / Profile preview

Tydra Labs

Vancouver, British Columbia, Canadagithub.com ↗

Ownership: Private
Development stage: Other

Overview

Tydra Labs develops sustainable, nature-inspired biomaterials by converting ocean waste through a proprietary fermentation process. Their products are designed for use in wound care, drug delivery, cosmetics, textiles, agriculture, water treatment, and food packaging. The company emphasizes biocompatibility and antimicrobial activity but does not appear to have clinical trial results yet[1].

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: BiologicNanoscale coatingsBiopolymer-based materialsSmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Tydra Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tydra Labs.

Explore the full profile